Commercial insights platform for pharma using AI.
ODAIA have been growing fast in recent years. The company began in the University of Toronto with an intensive period of R&D in AI, journey mapping, and process mining. From there, the ODAIA commercial insights platform for the pharmaceuticals industry was born. Their MAPTUAL solution uses AI and predictive analytics on a vast spread of data to segment and target physicians, thereby driving up customer engagement. Their rapid growth can be put down, in part, to a widespread shift in the way healthcare providers (HCPs) interact with Pharma, precipitated by the Covid pandemic. With on-site visits restricted, pharma reps needed to seek out different ways of forging meaningful client connections. What we’re seeing now is pharma messaging developing into more detailed, tailored forms of HCP support. As we’ve seen with marketing more generally, big data analytics is a phenomenally powerful tool for maintaining this competitive, tailored edge and funding awarded at the beginning of 2023 proves that ODAIA's AI is being tipped as a solution for the "bottleneck" in pharma delivery and testing. This means that ODAIA are blazing what is likely to prove an impressive trail in the new model of Pharma/HCP relations. Offering a more streamlined, modern method of targeting and value production, ODAIA is likely to prove an increasingly crucial player going forward in a highly lucrative market.